ArticleCritical care explorations2020

Evaluation of the Efficacy and Safety of Inhaled Epoprostenol and Inhaled Nitric Oxide for Refractory Hypoxemia in Patients With Coronavirus Disease 2019.

Jeremy R DeGrado et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.